Pharmafile Logo
Pharmafocus logo
Advanced Search

Oxford University

Showing 4 posts of 4 posts found.

shutterstock_38078521

AstraZeneca and Oxford Uni’s COVID-19 vaccine trial resumes following safety review

September 14, 2020
Research and Development, Sales and Marketing AstraZeneca, COVID-19, Oxford University, Vaccine

After sparking a wave of concern through industry and mainstream media with the news it had halted international studies investigating …

News
512px-oxford_university_colleges-all_souls1

AstraZeneca and Oxford University’s COVID-19 vaccine generates “robust immune responses” in early interim data

July 21, 2020
Manufacturing and Production, Research and Development AstraZeneca, COVID-19, Oxford University, Vaccine, coronavirus

Interim Phase 1/2 findings have been released for the COVID-19 highly anticipated vaccine candidate in development from Oxford University and …

News

UCB signs £3.6m research deal with Oxford University

March 20, 2012
Research and Development, Sales and Marketing Oxford University, UCB, collaboration, research

UCB Pharma and Oxford University have signed an R&D collaboration agreement covering immunology and neurology. The idea is to pool …

News

Sanofi signs new oncology research deals

December 20, 2010
Research and Development Avila Therapeutics, Cancer, INDOX, India, Oxford University, Sanofi, Sanofi-Aventis, cancer research, covalent drugs

Sanofi-Aventis has signed two new cancer research deals, including one that will see it partner with Avila Therapeutics to discover …

News

Latest content

Abcuro completes enrolment for phase 2/3 IBM treatment trial

June 26, 2024

AskBio initiates phase 2 Parkinson’s trial recruitment

June 26, 2024

AstraZeneca’s Tagrisso approved in Japan for lung cancer treatment

June 25, 2024

ILiAD Biotechnologies announces collaboration with Emmes Group on phase 3 pertussis vaccine trial

June 25, 2024

GSK’s Jemperli accepted for review by EMA for endometrial cancer treatment

June 24, 2024